✦ LIBER ✦

3544 POSTER Phase I study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy in gemcitabine-refractory pancreatic cancer patients.

✍ Scribed by C. Morizane; T. Okusaka; J. Furuse; H. Ishii; H. Ueno; M. Ikeda; T. Ogura; K. Nakachi; E. Suzuki

Book ID: 118625889
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 80 KB
Volume: 5
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(07)71047-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II study of gemcitabine as a fix

Phase I/II study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy (FGS) in gemcitabine-refractory pancreatic cancer patients

✍ Chigusa Morizane; Takuji Okusaka; Hideki Ueno; Shunsuke Kondo; Masafumi Ikeda; J 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 226 KB

6594 Phase II study of gemcitabine as a

6594 Phase II study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy (FGS) in gemcitabine-refractory pancreatic cancer patients

✍ Morizane, C.; Okusaka, T.; Ikeda, M.; Furuse, J.; Ohkawa, S.; Nakachi, K.; Suzuk 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

6595 POSTER Phase I Study of Gemcitabine

6595 POSTER Phase I Study of Gemcitabine as a Fixed Dose Rate Infusion and S-1 Combination Therapy (FGS) in Gemcitabine-refractory Biliary Tract Cancer (BTC) Patients

✍ Kojima, Y.; Ikeda, M.; Ueno, H.; Morizane, C.; Nakachi, K.; Mitsunaga, S.; Kondo 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

A phase 1 study of fixed dose rate gemci

A phase 1 study of fixed dose rate gemcitabine and irinotecan in patients with advanced pancreatic and biliary cancer

✍ Weijing Sun; Maureen R. Hewitt; Marry R. Theobald; Diane Hershock; Daniel G. Hal 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Abstract ## BACKGROUND. The combination of a fixed dose rate (FDR) infusion of gemcitabine and irinotecan may have a synergistic effect in the treatment of patients with advanced and metastatic pancreatic and biliary cancer. The current study was conducted to determine the dose‐limiting toxicit

A phase I study of prolonged infusion of

A phase I study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumors

✍ Mortazavi, Amir; Ling, Yonghua; Martin, Ludmila Katherine; Wei, Lai; Phelps, Mit 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 240 KB

Phase I dose-escalation study and popula

Phase I dose-escalation study and population pharmacokinetic analysis of fixed dose rate gemcitabine plus carboplatin as second-line therapy in patients with ovarian cancer

✍ Leijen, Suzanne; Veltkamp, Stephan A.; Huitema, Alwin D.R.; van Werkhoven, E.; B 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 306 KB